Skip to content

15-month longitudinal study of dietary and sunlight influences on vitamin D status in a well-characterised population of postmenopausal women at 57ºN

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN96210443
Enrollment
360
Registered
2007-10-16
Start date
2006-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low bone mass/risk of osteoporosis Musculoskeletal Diseases Osteoporosis

Interventions

This is a 15-month observational study starting in March 2006 aiming to assess how diet and sunlight exposure influence vitamin D status for each three-monthly season. There will be five visits in tot

Sponsors

Food Standards Agency (UK)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Women from a previous sceening study (Aberdeen Prospective Osteoporosis Screening Study - APOSS) aged less than 65 years.

Exclusion criteria

Exclusion criteria: Participants will be excluded if they: 1. Have chronic gastro-intestinal disease associated with malabsorption 2. Are taking oral corticosteroids 3. Are receiving bisphosphonate therapy (as there is a possibility of interaction with vitamin D metabolism)

Design outcomes

Primary

MeasureTime frame
Monitor longitudinally the seasonal variation in vitamin D status at a northerly latitude, assessing the individual contributions of sunlight and diet. All primary and secondary outcomes were measured at each visits, i.e., at Baseline (BL), 3-month, 6-month, 9-month and 12-month visits.

Secondary

MeasureTime frame
1. Monitor seasonal variation in physical activity (confounder of vitamin D status) 2. Monitor seasonal variation in: 2.1. Markers of bone turnover (functional marker) 2.2. Falls, muscle strength (functional markers not related to bone health) 3. Determine the relationship between vitamin D status, functional markers (Bone Mineral Density [BMD], bone resorption, muscle strength) with and without adjustment for physical activity level All primary and secondary outcomes were measured at each visits, i.e., at Baseline (BL), 3-month, 6-month, 9-month and 12-month visits; BMD was measured at 6-month and 9-month visits only.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026